Drug firm to open key digital lab
Print Edition
Boehringer Ingelheim announced yesterday that it will open a second branch of its digital lab BI X in Shanghai with an initial investment of 3 million euros (US$3.32 million).
This will be the first overseas branch for the drug firm’s digital venture outside its headquarters in Germany, and in Shanghai it aims to hire 20 new staff to develop innovative digital solutions for Chinese patients. The new branch is scheduled to open in July.
The company joins a number of multinationals that are eager to leverage the local digital landscape to forge closer ties with local startups and partners to create tailor-made solutions.
Boehringer Ingelheim’s digital lab aims to use digital innovation to accelerate the development of health-care cures and the discovery of breakthrough treatments.
Since its launch in 2017, BI X has brought together coders, data scientists, engineers and user experience designers to test and prove new applications within short time limits.
“With this step we are strengthening our footprint in a market that is very strong in digital innovation in health care and has a unique technological landscape,” said Michael Schmelmer, of Boehringer Ingelheim’s board of managing directors.
This year marks the 25th anniversary of Boehringer Ingelheim’s entry into China.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证：沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证：31120180004
- |
- 网络视听许可证：0909346
- |
- 广播电视节目制作许可证：沪字第354号
- |
- 增值电信业务经营许可证：沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
